Review and Reduction of Strategic Shareholdings
First written in FY2024. 2 of 3 entries say "Advanced", first in FY2025. Latest entry: FY2026.
- FY2026AdvancedAnnual report
「The holdings in NAGAILEBEN Co.,Ltd., JICHODO Co.,Ltd., KOBAYASHI PHARMACEUTICAL CO.,LTD., ONWARD HOLDINGS CO.,LTD. and SUMINOE Co.,Ltd. were changed from cross-shareholdings to holdings for pure investment purposes due to business withdrawals, and negotiations for their sale are planned.」
For the 5 holdings changed from holdings for policy purposes to holdings for pure investment purposes following business withdrawals, the Company disclosed its policy and plans for negotiations regarding their sale. - FY2025AdvancedAnnual report
「The Company’s policy is to promptly dispose of or reduce cross-shareholdings that it considers to have limited significance. Each year, the Board of Directors verifies the significance and economic rationality of individual cross-shareholdings and reviews whether to continue holding them and the number of shares held.」
The Company continued its policy of annual reviews by the Board of Directors and reducing cross-shareholdings, and disclosed the sale of 2 unlisted shareholdings during the fiscal year. - FY2024First statedAnnual report
「The Company’s policy is to promptly dispose of or reduce cross-shareholdings that it considers to have limited significance. Each year, the Board of Directors verifies the significance and economic rationality of individual cross-shareholdings and reviews whether to continue holding them and the number of shares held.」
The Company explicitly stated its policy of having the Board of Directors annually verify the significance and economic rationality of cross-shareholdings and dispose of or reduce holdings deemed to have limited significance. During the fiscal year, it sold 1 shareholding other than unlisted shares.